Skip to main content
Equibles

Benjamin F. Cravatt

Board Member

Alnylam Pharmaceuticals, Inc. (ALNY)

Equibles does not estimate personal net worth.

Get an email with a short summary when Alnylam Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get ALNY alerts

About Benjamin F. Cravatt

Benjamin F. Cravatt is recorded as Board Member at Alnylam Pharmaceuticals, Inc. (ALNY) since June 1, 2026. Alnylam Pharmaceuticals, Inc. reported in an 8-K filed May 27, 2026 that Benjamin F. Cravatt was appointed Class III director, effective June 1, 2026. Alnylam Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alnylam Pharmaceuticals, Inc. includes Yvonne Greenstreet (CEO and COO), Yvonne L. Greenstreet (CEO, COO and Board Member), Amy W. Schulman (Chairman and Board Member) and 7 others.

“Effective as of June 1, 2026, the Board of Directors (the "Board") of Alnylam Pharmaceuticals, Inc. (the "Company"), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company's Board from ten to eleven and elected Benjamin F. Cravatt, Ph.D. to fill the newly created vacancy.”
Alnylam Pharmaceuticals, Inc. Form 8-K, filed May 27, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Alnylam Pharmaceuticals, Inc.

Recent activity